Company intelligence / Profile preview

Welldoc

Columbia, Maryland, United Stateswelldoc.com ↗

Ownership: Private
Development stage: Commercial

Overview

Welldoc’s platform—including its FDA-cleared BlueStar solution—has demonstrated improved self-management and outcomes in type 1 and type 2 diabetes through multiple clinical studies. The company has over 90 clinical publications supporting the efficacy of its solutions for cardiometabolic conditions[3][5][6].

Therapeutic areas: EndocrinologyCardiovascular
Modalities: Device (Software as a Medical Device)Non-pharmacological therapyDigital therapeutic
Industry: Digital Health Medical Devices

Drug pipeline

1 asset

BlueStar

Commercial

Indications: Type 1 diabetes, Type 2 diabetes

Partnerships

Health plans, health systems, employerspartnerships with leaders in healthcare/life sciences/medical device industries[2][3][5]

Beyond the preview

Go deeper on Welldoc.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Welldoc.

Explore the full profile